Document ID: chunk:federal_register_of_legislation:C2015A00089:clause:1_6
Version: federal_register_of_legislation:C2015A00089
Segment Type: clause
Provision Reference: sch 1 cl 6
Character Range: 5152–6591

6  Section 99AC
Omit:

      Subdivision CA sets out the circumstances in which price reductions are required for new brands of pharmaceutical items that have the same drug as an existing brand of a pharmaceutical item that is subject to an outstanding staged reduction under section 99ACK. The listing of the new brand or brands also provides a trigger for price reductions to occur under Subdivision D (see sections 99ACM and 99ACN) for existing brands of pharmaceutical items that have that drug.
      Subdivision D provides for other price reductions for pharmaceutical items (including for combination items in some cases). These price reductions:
         (a) are triggered when Subdivision B applies to require a 16% price reduction to a new brand of a pharmaceutical item; or
         (b) are triggered when Subdivision CA applies to a new brand of a pharmaceutical item that has the same drug as an existing brand of a pharmaceutical item that is subject to an outstanding staged reduction; or
         (c) arise if the pharmaceutical item has a drug on F2 on a particular day.
substitute:

      Subdivision D provides for other price reductions for pharmaceutical items. These price reductions:
         (a) are triggered when Subdivision B applies to require a 16% price reduction to a new brand of a pharmaceutical item; or
         (b) arise if a pharmaceutical item has had a drug on F1 for 5 years on a particular day.